封面
市場調查報告書
商品編碼
2078316

藥物研發外包市場:依工作流程、治療領域、藥物類型、服務類型、最終用戶和地區分類

Drug Discovery Outsourcing Market, By Workflow, By Therapeutic Area, By Drug Type, By Service Type, By End User, By Region

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,藥物研發外包市場規模將達到 46.161 億美元,到 2033 年將達到 72.206 億美元。預計從 2026 年到 2033 年,該市場將以 6.6% 的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 46.161億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 6.60% 2033年市場規模預測: 72.206億美元

藥物研發外包是製藥和生技公司為降低藥物研發成本而採用的方法。將藥物的商業化委託給第三方專家,往往會對藥物的成功率產生顯著影響。為了滿足藥物研發服務的需求,多年來全球已建立了多種外包模式。

市場動態:

慢性病和危及生命的疾病日益普遍,對安全有效藥物的需求不斷成長,外包趨勢不斷擴大,對藥物研發的關注度不斷提高,以及外包服務的採用率不斷提高,預計這些因素將推動全球藥物研發外包市場在預測期內的成長。

例如,2023年4月,漢堡開始朝著成為歐洲學術藥物研發領域重要中心的目標邁進。這座德國北部城市的市政府宣布成立「歐洲篩選港有限公司」(European ScreeningPort GmbH),該公司將營運一個最先進的藥物研發服務中心。

本研究的主要特點:

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據公司概況、產品系列、主要亮點、財務表現和策略等參數,介紹了全球藥物研發外包市場主要參與者的概況。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份《全球藥物研發外包市場報告》旨在為產業內的各類相關人員提供參考,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用全球藥物研發外包市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 慢性病和危及生命的疾病造成的負擔日益加重
    • 藥物研發高成本
    • 外包服務的擴展
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特五力分析
  • 併購情景

第4章:全球藥物研發業務外包

  • 供給面和需求面分析
  • 經濟影響

第5章 全球藥物研發外包市場:依工作流程分類,2021-2033年

  • 目標識別和篩檢
  • 目標檢驗和功能資訊學
  • 先導化合物的篩選與最佳化
  • 臨床前開發
  • 其他相關工作流程

第6章 全球藥物研發外包市場:依治療領域分類,2021-2033年

  • 呼吸系統
  • 疼痛與麻醉
  • 腫瘤學
  • 眼科
  • 血液學
  • 心血管系統
  • 內分泌
  • 消化器官系統
  • 免疫調節
  • 感染疾病物
  • 中樞神經系統
  • 皮膚科
  • 泌尿生殖系統

第7章 全球藥物研發外包市場:依藥物類型分類,2021-2033年

  • 低分子
  • 聚合物化合物

第8章 全球藥物研發外包市場:依服務類型分類,2021-2033年

  • 化學服務
  • 生物服務

第9章 全球藥物研發外包市場:依最終用戶分類,2021-2033年

  • 製藥和生物技術公司
  • 學術機構

第10章 全球藥物研發外包市場:依地區分類,2021-2033年

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第11章 競爭格局

  • Curia
  • Genscript
  • Evotec
  • Eurofins Scientific
  • Laboratory Corporation of America Holdings

第12章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI2847

Drug Discovery Outsourcing Market is estimated to be valued at USD 4,616.1 Mn in 2026 and is expected to reach USD 7,220.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 4,616.1 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.60% 2033 Value Projection: USD 7,220.6 Mn

Drug discovery outsourcing is a practice used by pharmaceutical and biotechnology companies to reduce the cost of drug development. Outsourcing pharmaceutical drug commercialization to third party experts often can make a notable difference in the level of success of the given drug product. There are several outsourcing models that have been created worldwide over the years to address drug development service needs.

Market Dynamics:

Increasing prevalence of chronic/life-threatening disease, increasing demand for safe and effective drugs, growing trend of outsourcing, rise in focus on drug development, and increase in adoption of outsourcing services are major factors expected to augment growth of the global drug discovery outsourcing market during the forecast period.

For instance, in April 2023, Hamburg is on its way to becoming a leading hub of Europe's academic drug discovery, with the northern German city's town hall announcing the foundation of European ScreeningPort GmbH (European Centre for Modern Drug Discovery), a company that will run a state-of-the-art drug discovery service centre.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global drug discovery outsourcing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Curia, Genscript, Evotec, Eurofins Scientific, Laboratory Corporation of America Holdings, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global drug discovery outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug discovery outsourcing market.

Detailed Segmentation:

  • Global Drug Discovery Outsourcing Market, By Workflow (Revenue, USD Mn, 2021 - 2033)
  • Target Identification & Screening
  • Target Validation & Functional Informatics
  • Lead Identification & Candidate Optimization
  • Preclinical Development
  • Other Associated Workflow
  • Global Drug Discovery Outsourcing Market, By Therapeutic Area (Revenue, USD Mn, 2021 - 2033)
  • Respiratory System
  • Pain and Anesthesia
  • Oncology
  • Ophthalmology
  • Hematology
  • Cardiovascular
  • Endocrine
  • Gastrointestinal
  • Immunomodulation
  • Anti-Infective
  • Central Nervous System
  • Dermatology
  • Genitourinary System
  • Global Drug Discovery Outsourcing Market, By Drug Type (Revenue, USD Mn, 2021 - 2033)
  • Small Molecule
  • Large Molecule
  • Global Drug Discovery Outsourcing Market, By Service Type (Revenue, USD Mn, 2021 - 2033)
  • Chemistry Services
  • Biology Services
  • Global Drug Discovery Outsourcing Market, By End User (Revenue, USD Mn, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles:
  • Curia
  • Genscript
  • Evotec
  • Eurofins Scientific
  • Laboratory Corporation of America Holdings

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Workflow
    • Market Snapshot, By Therapeutic Area
    • Market Snapshot, By Drug Type
    • Market Snapshot, By Service Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in burden of chronic or life-threatening diseases
    • High cost of drug development
    • Increase in adoption of outsourcing services
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER€(TM)s Analysis
  • Merger and Acquisition Scenario

4. Global Drug Discovery Outsourcing

  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Drug Discovery Outsourcing Market, By Workflow, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Target Identification & Screening
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Target Validation & Functional Informatics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Lead Identification & Candidate Optimization
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Preclinical Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Other Associated Workflow
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Global Drug Discovery Outsourcing Market, By Therapeutic Area, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Respiratory System
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Pain and Anesthesia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Ophthalmology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Hematology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Endocrine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Gastrointestinal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Immunomodulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Anti-Infective
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Central Nervous System
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Dermatology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Genitourinary System
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

7. Global Drug Discovery Outsourcing Market, By Drug Type, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Small Molecule
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Large Molecule
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

8. Global Drug Discovery Outsourcing Market, By Service Type, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Chemistry Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Biology Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

9. Global Drug Discovery Outsourcing Market, By End User, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

10. Global Drug Discovery Outsourcing Market, By Region, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)

11. Competitive Landscape

  • Curia
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Genscript
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Evotec
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Eurofins Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Laboratory Corporation of America Holdings
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

12. Section

  • Research Methodology
  • About us